الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 146 |  |  |
| | | from | 146 | | |
Abstract
Bleeding from gastric varices is a life-threatening complication
of portal hypertension. Fundal and isolated gastric varices are at
high risk for variceal bleeding (Dhiman et al., 2002).
Bleeding in the patient with cirrhosis remains one of the most
demanding clinical challenges that a gastroenterologist or
gastrointestinal surgeon may face (Chung, 2002).
Esophagogastric varices are one of the most common
complications (varices, ascites, hypersplenism and encephalopathy)
of portal hypertension. Endoscopic sclerotherapy is the first choice
for esophago-gastric varices today. However, immediate surgical
intervention always needed whenever endoscopic therapy fails to
control acute bleeding (Wu et al., 2002).
Varices can be found on the stomach of a patient with portal
hypertension either isolated or in conjuction with esophageal
varices. The overall prevalence of gastric varices is variable
between 10% and more than 50%. Isolated gastric varices in the
absence of esophageal varices are rare with reported incidence
between 5% and 12% in patients with varices (Kim et al., 1997).
The tissue adhesive N-butyl-2-cyanoacrylate (histoacryl, Braun,
Melsungen, Germany) have been used to treat oesophageal and gastric varices outside the USA for more than one decade.
Histoacryl is the most available agent and has been used in most
studies (Muhammad and Whitney, 1999).
Bleeding from gastric varices is difficult to control and has a
high mortality rate. Surgical intervention is still advocated.
(Tomikawa et al., 2002).